Background: Escherichia coli is the most important as well as the most common bacteria causing urinary tract infections (UTIs) and its resistance to common antibiotics is increasing. Extended-spectrum beta-lactamase (ESBL) producer E. coli strains can resist against the third-generation and fourth-generation cephalosporins. Objectives: This study aimed to evaluate the resistance profile of E. coli isolated from patients with UTIs referred to Imam Khomeini and Baqiyatallah Hospitals, Tehran, Iran, through phenotypic and molecular methods. Materials and Methods: During 2010-2011, 180 urine samples of patients with UTIs from Imam Khomeini and Baqiyatallah Hospitals were collected. Based on the standard bacteriologic tests, E. coli isolates were identified. Resistance to common antibiotics was tested by the Kirby-Bauer method and reconfirmed by determining minimum inhibitory concentration (MIC) through microdilution method. Further phenotypic double-disk synergy test (DDST) was performed to screen the ESBL producer strains. Resistance genes related to ESBL and qnrA were evaluated by Polymerase chain Reaction (PCR). Results: A total of 100 E. coli strains were examined by antibiogram and the rates of resistance to the tested antibiotics were as follows: 100% to penicillin and amoxicillin, 77% to amoxicillin-clavulanic acid, 72% to ceftazidime, 69% to cefotaxime, 47% to cefoxitin, 46% to ceftriaxone, 43% to cephalexin, 27% to aztreonam, 53% to nalidixic acid, 51% to ciprofloxacin, and 2% to imipenem. The MIC to ciprofloxacin, cefazolin, and ceftriaxone were ≥ 0.249, ≥ 0.508, and ≥ 0.044, respectively. Moreover, 20% of E. coli isolates were ESBL-producing isolates by DDST. The frequency of bla CTX-M, bla TEM, bla SHV, and qnrA genes was 87%, 82%, 65%, and 39%, respectively. Conclusions: Considering the high prevalence of ESBL genes (bla CTX-M, 87%; and bla TEM, 82%), fluoroquinolones may be used as an alternative drug in treatment, although resistance to this family is increasing as well. As a result, this increasing trend should be prevented using appropriate guidelines for prescription.
Background
Escherichia coli is the most common bacterial agent causing urinary tract infections (UTIs). Cephalosporins, especially the third-generation ones, are used as a routine treatment for UTIs and fluoroquinolones are used increasingly as new alternative treatment of choice (1) . During the recent years, these bacteria have undergone mutation and became resistant to many antibiotics by exchanging the resistant genes (2) . One of the resistance mechanisms is producing enzymes like beta-lactamase and extended-spectrum beta-lactamases (ESBLs) that can hydrolyze the beta-lactam ring and inactivate these drugs that contain this structural element. Major reports of ESBL production are related to bla CTX-M, bla TEM and bla SHV as plasmid genes, which can simultaneously carry other resistant genes (3) (4) (5) (6) (7) . As mentioned before, the fluoroquinolones are another choice for treatment of betalactam-resistant bacteria (8, 9) . Similarly, some plasmid genes like qnrA are responsible for quinolone resistance.
Objectives
The aim of this study was to evaluate the resistance profile of E. coli, isolated from urine samples of the patients with UTIs, to routine antibiotics especially beta-lactams and ciprofloxacin.
Materials and Methods
In this study, 180 urine samples were collected from patients with UTI referred to Imam Khomeini and Baqiyatallah Hospitals, Tehran, Iran, during September 2010 to March 2011. After special identification tests including EMB (eosin-methylene blue agar), TSI (Triple Sugar Iron agar), SIM (SH 2 , Indole and Motility), MR-VP (Methyl Red VogesProskauer Broth), and Citrate, 100 E. coli isolates were randomly selected for further investigation. Their resistance to common antibiotics, namely, imipenem, ceftriaxone, penicillin, amoxicillin, amoxicillin-clavulanic acid, ciprofloxacin, nalidixic acid, cefixime, cephalexin, cefotaxime, ceftazidime, and aztreonam discs (all from Himedia Company, India) was assessed according to the Clinical and Laboratory Standards Institute (CLSI) protocol and by the Kirby-Bauer method (10) . In further step, minimal inhibitory concentration (MIC) was determined by microdilution method for ceftriaxone, cefazolin, and ciprofloxacin in accordance with CLSI protocol (10) . Simultaneously, E. coli ATCC 25922 was used as the control. In the next step, ESBL production was assessed by double-disk synergy test (DDST) and using cefotaxime with and without clavulanic acid and ceftazidime with and without clavulanic acid discs. In this test, the antibiotic disks alone and with clavulanic acid were placed 25 mm apart from each other (10) . More than or equal to 5 mm increase in the diameter of the growth inhibition zone of the antibiotic with clavulanic acid in comparison to the disk alone showed positive results for the ESBL production (11, 12) . For molecular investigation, DNA extraction was done using DNA Extract Kit (Taif Ara, Iran) and consequently polymerase chain reaction (PCR) method was employed to assess the frequency of resistance genes including bla CTX-M, bla SHV, and bla TEM for ESBLs genotyping and qnrA gene for ciprofloxacin resistance study (13, 14) . More details about the sequence of used primers and PCR programming are shown in Tables  1 and 2 . The PCR products were analyzed after gel electrophoresis, stained by ethidium bromide, and exposed to the UV radiation. During PCR, ESBL-positive Klebsiella pneumonia ATCC 700603 was used as the positive control.
Results
According to the identification tests, 100 confirmed E. coli isolates were selected for the experiment; 79% of the samples were collected from adults (females, 51%; and males, 28%) and 21% from children. The frequency of the samples based on the hospital wards was as follows: gynecology, 36%; urology, 15%; neurology, 14%; miscellaneous wards, 10%; and outpatient clinics, 25%. According to the antibiogram test, the rates of resistance of the bacteria to antibiotics was as follows: amoxicillin and penicillin, 100%; ceftazidime, 72%; cefotaxime, 69%; nalidixic acid, 53%; ciprofloxacin, 51%; cefoxitin, 47%; cephalexin, 43%; aztreonam, 27%; and imipenem, 2% (Figure 1) . In microdilution test, the MIC of resistant strains to ceftriaxone, cefazolin, and ciprofloxacin was ≥ 0.044, ≥ 0.508, and ≥ 0.249, respectively. By DDST test, 20% of the E. coli isolates showed ≥ 5 mm increase in the diameter of the growth inhibition zone around the clavulanic acid disks and were marked as ESBL-positive isolates ( Figure  2 ). In the PCR test, after preparing the required conditions, the frequency of bla CTX-M, bla TEM, bla SHV, and qnrA genes was 87%, 82%, 65%, and 40%, respectively (Figures 3 and 4) . 
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Discussion
In this study, the rate of resistance of the isolated E. coli strains to ampicillin and penicillin was 100% and this is an alarm for clinicians to pay more attention to the amount of consumption and prescription of these antibiotics. From 2002 to 2004, in Minnesota, USA, 931 specimens of E. coli were isolated from the urine samples of two groups, i.e. patients and controls, and their resistance to the fluoroquinolones was studied. In addition, the existence of resistance genes to fluoroquinolones, trimethoprim/sulfamethoxazole, and cephalosporins as well as the ability of ESBL production were analyzed by molecular PCR method. According to the results, the resistance rate to fluoroquinolones was higher in the hospitalized patients than in controls (15) . Resistance of these bacteria was 100% to penicillin and amoxicillin, 43% to cephalexin, 46% to ceftriaxone, and 2% to imipenem; these results revealed a high trend of resistance to the common antibiotics used in the routine treatment of UTIs. In addition, Warburg et al. studied the resistance rate of E. coli isolates to fluoroquinolones and screened the frequency of qnrA, qnrB and aac(6')-lb-cr genes by using PCR during 1991-2005; they found that not only is the resistance to ciprofloxacin growing but also most of these strains produce ESBL. Therefore, gene translocation by plasmids plays an important role in this regard. Moreover, taking the results into account, a hypothesis suggests that there
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is a correlation between resistance to fluoroquinolones and synchronous ability of ESBL production because of the relation between these two plasmids (16) . For this reason, the existence of qnrA gene among ESBL-positive E. coli strains was evaluated and based on its results, special attention must be paid to these strains during therapy.
In a five-year study in Houston, Texas, USA, the relation between resistance to fluoroquinolones and age as well as sex was studied and it revealed that the increase in age and duration of hospitalization accelerated the rate of resistance to fluoroquinolones in males (17) . In another study in Norway, resistance of E. coli strains, taken from the urine of the patients with UTI, to ciprofloxacin and nalidixic acid by disk diffusion method showed 1% increase during a four-year period. In the mentioned study, most specimens were taken from women (83%). Then resistance to ciprofloxacin, trimethoprim, ampicillin, sulfonamide, nitrofurantoin, nalidixic acid, chloramphenicol, tetracycline, and gentamicin was studied by the phenotypic method and finally by using PCR and pulse-field method and the presence of genes involved in resistance was determined (18) . Resistance to two routine drugs of the fluoroquinolones group, namely, nalidixic acid and ciprofloxacin was determined respectively to be 14% and 2% by using the disk diffusion method. In our study, resistance rate to nalidixic acid and ciprofloxacin were 53% and 51%, respectively. In a study by Johnson et al. in Canada, the changes in resistance to ofloxacin, a fluoroquinolone, were evaluated; they found that the resistance rate to this drug had increased from 1% to 9% within a five-year period. They concluded that factors like duration of hospitalization and irregular use of these drugs had led to increased resistance (19) . Similarly, increase in resistance of E. coli isolated from the urine of patients with UTIs to ciprofloxacin was attributed to the irregular consumption of fluoroquinolones in Switzerland (20) .
According to the results of our study, the rate of resistance to beta-lactam drugs is increasing and treatment is difficult. This increasing trend of resistance has been seen with fluoroquinolones and synchronous resistance to these two antibiotic groups has been seen in most strains. As a result, we recommend to perform antibiogram test before prescribing any drug in order to prevent the increasing trend of resistance to fluoroquinolones and beta-lactam drugs.
